BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36460623)

  • 1. RAMP: response-aware multi-task learning with contrastive regularization for cancer drug response prediction.
    Lee K; Cho D; Jang J; Choi K; Jeong HO; Seo J; Jeong WK; Lee S
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36460623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
    Li Y; Guo Z; Gao X; Wang G
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38070154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction.
    Liu X; Song C; Huang F; Fu H; Xiao W; Zhang W
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34727569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular data representation based on gene embeddings for cancer drug response prediction.
    Park S; Lee H
    Sci Rep; 2023 Dec; 13(1):21898. PubMed ID: 38081928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-based drug sensitivity prediction.
    Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting microbe-drug associations with structure-enhanced contrastive learning and self-paced negative sampling strategy.
    Tian Z; Yu Y; Fang H; Xie W; Guo M
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36715986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
    Pang W; Chen M; Qin Y
    BMC Bioinformatics; 2024 May; 25(1):182. PubMed ID: 38724920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarity measures-based graph co-contrastive learning for drug-disease association prediction.
    Gao Z; Ma H; Zhang X; Wang Y; Wu Z
    Bioinformatics; 2023 Jun; 39(6):. PubMed ID: 37261859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving cancer driver gene identification using multi-task learning on graph convolutional network.
    Peng W; Tang Q; Dai W; Chen T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34643232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning.
    Gönen M; Margolin AA
    Bioinformatics; 2014 Sep; 30(17):i556-63. PubMed ID: 25161247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
    Peng W; Liu H; Dai W; Yu N; Wang J
    Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.
    Wang C; Zhang M; Zhao J; Li B; Xiao X; Zhang Y
    Comput Biol Med; 2023 Sep; 163():107220. PubMed ID: 37406589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOViDA: multiomics visible drug activity prediction with a biologically informed neural network model.
    Ferraro L; Scala G; Cerulo L; Carosati E; Ceccarelli M
    Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37432499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.
    Ammad-Ud-Din M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2017 Jul; 33(14):i359-i368. PubMed ID: 28881998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving anti-cancer drug response prediction using multi-task learning on graph convolutional networks.
    Liu H; Peng W; Dai W; Lin J; Fu X; Liu L; Liu L; Yu N
    Methods; 2024 Feb; 222():41-50. PubMed ID: 38157919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
    Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
    Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transfer learning approach via procrustes analysis and mean shift for cancer drug sensitivity prediction.
    Turki T; Wei Z; Wang JTL
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840014. PubMed ID: 29945499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian multitask learning for medicine recommendation based on online patient reviews.
    Cheng Y; Xia Y; Wang X
    Bioinformatics; 2023 Aug; 39(8):. PubMed ID: 37551956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling.
    Pu L; Singha M; Ramanujam J; Brylinski M
    Oncotarget; 2022; 13():695-706. PubMed ID: 35601606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.